Sofinnova Venture Partners XI, L.P. - Sep 11, 2025 SCHEDULE 13D/A Report for Rapport Therapeutics, Inc. Common Stock, $0.001 par value (RAPP)

Filing Manager
Sofinnova Venture Partners XI, L.P.
Reporting Manager
Dr. James I. Healy ("Healy")
Security
Rapport Therapeutics, Inc. Common Stock, $0.001 par value
Symbol
RAPP
Shares outstanding
46.4M shares
Disclosed Ownership
1.95M shares
Ownership
4.2%
Form type
SCHEDULE 13D/A
Date filed
9/18/2025, 05:32 PM
Date of event
Sep 11, 2025
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Sofinnova Venture Partners XI, L.P. ("SVP XI") 4% 1.86M 1.86M 0 /s/ Nathalie Auber Nathalie Auber/Attorney-in-Fact 0001882303
Sofinnova Management XI, L.P. ("SM XI LP") 4% 1.86M 1.86M 0 /s/ Nathalie Auber Nathalie Auber/Attorney-in-Fact
Sofinnova Management XI, L.L.C. ("SM XI LLC") 4% 1.86M 1.86M 0 /s/ Nathalie Auber Nathalie Auber/Attorney-in-Fact
Dr. James I. Healy ("Healy") 4.2% 1.95M 4.82K 1.95M /s/ Nathalie Auber Nathalie Auber/Attorney-in-Fact
Dr. Maha Katabi ("Katabi") 4% 1.86M 0 1.86M /s/ Nathalie Auber Nathalie Auber/Attorney-in-Fact